CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,721 | -9.7% | 330 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $10,764 | -7.3% | 330 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $11,612 | -23.2% | 330 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $15,120 | +0.8% | 330 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $15,000 | +25.0% | 330 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $12,000 | 0.0% | 330 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $12,000 | -20.0% | 330 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $15,000 | +1400.0% | 330 | +230.0% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 100 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 100 | -42.9% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 175 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -66.7% | 175 | +20.7% | 0.00% | -100.0% |
| Q3 2017 | $3,000 | +50.0% | 145 | -17.1% | 0.00% | 0.0% |
| Q2 2017 | $2,000 | 0.0% | 175 | -32.7% | 0.00% | -50.0% |
| Q1 2014 | $2,000 | – | 260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |